BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020.

More here:
Teligent, Inc. Announces Third Quarter 2020 Results

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *